ATORVASTATIN ON CLEARANCE RATE OF POSTPRANDIAL TRIGLYCERIDE RICH LIPOPROTEINS
ATORVASTATIN ON CLEARANCE RATE OF POSTPRANDIAL TRIGLYCERIDE RICH LIPOPROTEINS
批准号:
6123533
负责人:
P HUGH BARRETT
金额:
$2.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2000-02-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Elevated low density lipoprotein cholesterol (LDL-C) levels are a
major risk factor for coronary heart disease. One approach to
determining some of the factors responsible for elevated LDL-C has
involved performing lipoprotein turnover studies. Such studies
determine the pathways of lipoprotein metabolism and quantify the
rates of production and catabolism of the different lipoprotein
species. With the technology now readily available for using stable
isotopes to trace the different apolipoproteins, there has been
renewed interest in performing such studies. In addition, with the
use of stable isotopes has come the ability to perform multiple
turnover studies in the same individual under different experimental
conditions, such as drug therapy and/or dietary changes. The use of
radioactive tracers in the past limited the experimenters ability to
perform multiple turnover studies because of risks associated with
radiation exposure.
Many compartmental models of lipoprotein metabolism have been
developed in the past thirty years (1 -5). S10b models have been fit
to an individual's data set to determine the kinetic parameters of
interest. To deternibw group kinetic parameters, averages of the
kinetic parameters are calculated ignoring the errors associated WW
the individual parameters or the covariances between the parameters.
Further, no studies have integrated tile information obtained
following the fitting process with other covariates, such as measures
of obesity hypertension, dyslipidernia and insulin resistance.
Conclusions drawn from tracer studies may be confoUn by the lack of
understanding of population variability and also because covariates
have not been included in% analysis of the kinetic data
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金